Edity Therapeutics announced a strategic collaboration with Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) to create novel cell therapy medicines by applying Edity’s proprietary delivery platform.
Read more here.
![[Axiom Space in CNBC] Axiom Space raises $350 million from Saudi and Korean investors](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
